🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UPDATE 2-European stocks gain on vaccine, stimulus hopes; earnings eyed

Published 2020/07/13, 10:59
Updated 2020/07/13, 18:30
© Reuters.
ALFA
-
NELES
-
UBIP
-
DNB
-
NOD
-
STOXX
-
OSEAX
-
SXEP
-
STOXXE
-
SX7P
-
SXAP
-
SXPP
-
SXTP
-
ESSITYb
-

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

* Pfizer (NYSE:PFE), BioNTech's coronavirus vaccines make progress

* Finland's Neles at record high on Alfa Laval bid

* Ubisoft sinks after major management reshuffle

* STOXX 600 near 1-week high

(Updates to close)

By Sruthi Shankar and Susan Mathew

July 13 (Reuters) - European shares rose on Monday as progress on a possible COVID-19 vaccine, some upbeat earnings reports and stimulus talks fed into hopes of an economic recovery from the coronavirus-induced downturn.

The pan-European STOXX .STOXX index rose 1%, with miners .SXPP gaining 1.7% on optimism over China's recovery and surging metal prices. .SS MET/L

Other growth-oriented sectors such as travel & leisure .SXTP , banks .SX7P , technology stocks .SX8P and oil & gas .SXEP rose between 1.9% and 1.4%.

Two experimental coronavirus vaccines by German biotech firm BioNTech BNTX.O and U.S. pharmaceutical giant Pfizer PFE.N have received the U.S. Food and Drug Administration's "fast track" designation, the companies said on Monday. sooner a vaccine comes out the more confident economies can get about opening up completely and start to get on the road to recovery," said Michael Baker, analyst at ETX Capital in London. He added that optimism also stems from the fact that the companies involved are ones with the capacity to mass-produce.

Shares of BioNTech's depository receipt 22UAy.F on the Frankfurt exchange jumped 13.5%.

This week also kicks off the U.S. and European quarterly earnings season and includes a summit over the European Union recovery fund and a European Central Bank policy meeting.

"There appears to be some optimism that forecasts have been lowered to such an extent that businesses will be able to clear this low bar and surpass expectations," AJ Bell Investment Director Russ Mould said.

Companies listed on the STOXX 600 are expected to report a 54% drop in second-quarter profit, the worst ever reading for Europe, according to Refinitiv data.

Nordic bank DNB DNB.OL rose 9.9% after an earnings beat, while private security company G4S (CSE:G4S) GFS.L gained 9.3% on announcing that first-half profit would surpass expectations. the ECB is not expected to make a major move, European leaders will meet on July 17-18 to hammer out details on the $750 billion euro recovery fund. markets have taken comfort from trillions of dollars in stimulus even as the World Health Organization reported a record increase in global coronavirus cases on Sunday. other company news, Finnish valves maker Neles NELES.HE surged 37.6% and hit a record high after Swedish industrial group Alfa Laval ALFA.ST announced a recommended 1.73 billion euro ($1.96 billion) cash bid. Atlantia ATL.MI slumped 15.2% after Italy's prime minister dismissed the toll road operator's bid to keep its lucrative toll road concession. video games group Ubisoft UBIP.PA fell 5% as it announced staff departures after a review in response to allegations of misconduct at the company.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.